Found 62 matching trials
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma PHASE1 This phase I trial tests the safety, side effects, and best dose of nivolum...
Show More Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy PHASE3 This is a Phase 3, randomized, multinational, double-blind, dual placebo-co...
Show More Status
Active Not Recruiting
Location
Arizona Oncology Associates, PC - HAL
Learn More & Join Trial
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin Lymphoma PHASE2 This phase II trial compares the impact of brentuximab vedotin and nivoluma...
Show More Location
Multiple Locations
Learn More & Join Trial
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma N/A This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Show More Location
The Second Affiliated Hospital of Fujian Medical University
Learn More & Join Trial
A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER) PHASE1 This is a first-in-human study evaluating the anti-T cell immunoglobulin an...
Show More Status
Active Not Recruiting
Location
GSK Investigational Site
Learn More & Join Trial
FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors PHASE1 This is a Phase 1 dose-finding study of FT536 given in combination with a m...
Show More Location
Honor Health Research Institute
Learn More & Join Trial
Tesetaxel Plus 3 Different PD-(L)1 Inhibitors in Patients With Triple-Negative MBC and Tesetaxel Monotherapy in Patients With HER2-Negative MBC PHASE2 CONTESSA TRIO is a multi-cohort, multicenter, Phase 2 study of tesetaxel, a...
Show More Location
Sarah Cannon Research Institute - Florida Cancer Specialists
Learn More & Join Trial
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors PHASE1 This is an open-label, dose escalation and expansion study to evaluate the ...
Show More Location
UCSF Helen Diller Family Comprehensive Cancer Center
Learn More & Join Trial
Platform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel Combinations PHASE1 This study is designed to evaluate multiple clinical hypotheses and mechani...
Show More Learn More & Join Trial
BMS-986012 in Relapsed/Refractory SCLC PHASE1 The purpose of this study is to determine the safety, tolerability, pharmac...
Show More Location
Local Institution - 0004
Learn More & Join Trial